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Objectives: To develop a per-patient volume correction for maximum flow rate using
multiple home uroflowmetry, and to carry out a pilot study to determine the most
prognostically useful volume at which to evaluate this measurement and estimate its
relationship with outcome from disobstructive bladder outlet surgery.
Methods: A total of 30 men carried out home uroflowmetry using a portable device
and completed symptom scores before surgery. This was repeated at least 4 months
after surgery. For each man’s presurgery flow data, voided volume was plotted against
maximum flow rate, and a line of best fit with logarithmic form calculated. This allowed
maximum flow rate to be corrected for any volume. Percentage reduction in symptom
score and increase in mean maximum flow rate were correlated with volume-corrected
maximum flow rates.
Results: Corrected maximum flow rate at all volumes showed the expected negative
correlation with both outcome measures. A statistically significant correlation occurred
for volumes >190 mL, with the best performance at volumes >300 mL.
Conclusions: We have devised a novel method allowing estimation of maximum flow
rate at any volume, which is a step forward for non-invasive diagnostics. We found this
volume-corrected maximum flow rate to correlate significantly with treatment outcome
at sufficiently high volumes.
Key words: bladder outlet obstruction, home monitoring, nomograms, transurethral
resection of prostate, uroflowmetry.
Introduction
The decision to carry out surgery for BOO in men with LUTS is guided by uroflowmetry.
Typically a one-off measurement of Qmax is obtained using office-based uroflowmetry. There
is evidence that when multiple measurements of Qmax are made for an individual, either the
highest1 or average2 Qmax improves diagnostic accuracy for BOO.
Ideally, in order to control for dependency on Vblad, Qmax should be measured at a specific
volume, but this is impractical. Clinical guidelines recommend that the Vvoid should be at least
150 mL, but this is not always feasible for men with habitual low Vvoid.
3,4
Nomograms have been developed enabling Qmax to be evaluated in the context of Vblad or
Vvoid, using relationships derived from large groups.
5,6 However, the relationship between
Qmax and volume varies between individuals.
7 These nomograms do not necessarily improve
diagnostic accuracy, because a larger volume might not actually mean an increased Qmax in a
particular individual.
We aimed to develop a per-patient correction for flow rate using multiple measurements of
Qmax and Vvoid from home uroflowmetry, and carry out a pilot study to determine the most
prognostically useful volume at which to evaluate this derived measurement of Qmax and esti-
mate its relationship with outcome from surgery for BOO.
Methods
All men scheduled for bladder outlet surgery for LUTS within the Freeman Hospital, New-
castle Upon Tyne, UK, were eligible for invitation into the study. Exclusion criteria were the
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presence of an indwelling urinary catheter or need for inter-
mittent self-catheterization. After research approvals and writ-
ten consent, each man was given a home uroflowmeter and
asked to record as many voids as possible for 1 week. They
also completed an IPSS questionnaire. This assessment was
repeated at least 4 months after surgery. The decision to carry
out surgery was made before study enrollment.
The objective outcome from surgery was defined as the
increase in mean Qmax measured by home uroflowmetry.
Symptom outcome from surgery was defined as the percent-
age reduction in total IPSS score.8,9
The home flowmeter (Fig. 1) was developed in the Regio-
nal Medical Physics Department, Newcastle Upon Tyne
Hospitals NHS Foundation Trust. It consists of a jug that is
placed on a measurement base unit before voiding into the
jug. Volume and flow rate are measured by a weight trans-
ducer. It is intended for unsupervised use by patients, and is
designed for ease of use, with no controls. It records all
voids onto inbuilt memory for up to 2 weeks, after which
data are downloaded to a computer. Software obtains Qmax,
Vvoid, date, time, duration and a flow trace for each void.
The accuracy of its volume and flow rate measurements is
within 5% relative to full scale (1000 mL and 50 mL/s,
respectively), as recommended by the current clinical guide-
line at the time.10 Each void was checked visually to verify,
and if necessary correct, automated calculation of void start,
void end, Vvoid and Qmax.
Urine flow rate depends on Vblad.
11 Hence Siroky et al.
developed nomograms relating flow rate to Vblad according to
a polynomial relationship. The home flowmeter measures
Vvoid, requiring assessment of PVR for Vblad to be known.
12 At
present, there are no tools available for patients to measure
their own PVR at home after each void. We therefore used
Vvoid as a surrogate for Vblad. Using measurements of Qmax
and Vvoid from presurgery home uroflowmetry, we planned to
calculate an equation of best fit for each man in order to pre-
dict Qmax from Vvoid. This required selection of the form these
equations would take. The Liverpool nomograms are the most
widely cited nomograms relating Qmax to Vvoid in men. They
were constructed from single measurements of flow obtained
from 331 male volunteers with no history of LUTS or bladder-
related surgery.6 The nomograms are based on equation (1).
ffiffi
ð
p
QmaxÞ ¼ 2:37þ 0:18
ffiffi
ð
p
VvoidÞ  0:014 (ageÞ (1)
Two nomograms were chosen with 35 and 60 years for the
age term, representing the median ages of the <50 years and
≥50 years cohorts, respectively. We therefore selected a
square root relationship for the equations used to predict
Qmax from Vvoid before surgery for each man. The equations
took the form shown in equation (2).
ffiffi
ð
p
QmaxÞ ¼ ðb1Þ 
ffiffi
ð
p
VvoidÞ þ ðb2Þ (2)
Coefficients b1 and b2 were unique for each patient. These
parameters were calculated using MATLAB vR2012 software
(MathWorks, Natick, MA, USA) to minimize the residual
sum of squares between the line described by this equa-
tion and the Qmax values recorded by the home flowmeter. A
point at (Vvoid,Qmax) = (0,0) was included for calculating the
coefficients. To illustrate this methodology, Figure 2 shows
examples of this equation for two patients, superimposed over
the Liverpool nomogram for men aged ≥50 years. Using
these equations, a set of “volume-corrected” Qmax (Qmax@-
Vol) values for each individual was calculated for volumes
from 0 to 500 mL at 5-mL intervals, as shown in Figure 3.
At each volume, the corrected Qmax values for the group
were correlated with outcome using Spearman’s rank, giving
a correlation coefficient (rho) and P-value. This allowed cal-
culation of the volume at which the Qmax@Vol values per-
formed best in terms of predicting outcome in the study
population.
For this feasibility study, we considered that results from a
group of 30 men would be sufficient to determine feasibility
of the use of home uroflowmetry and analyses in this context,
and to estimate the predictive value for treatment outcome to
power follow on studies.12 Statistical analyses were carried
out using MATLAB vR2012 software.
Results
We recruited 33 men between January and September 2012.
One man withdrew after the first period of recording because
of ill health, a second man’s prostate procedure was delayed,
preventing collection of outcome data and a third partici-
pant’s operation was postponed after heart surgery. This left
30 datasets available for analysis. The surgical procedures
carried out for these 30 men, all for relief of BOO, were: dia-
thermy transurethral resections of the prostate (19); holmium
laser enucleation of the prostate (7); potassium titanyl phos-
phate laser vaporisation of the prostate (3); and holmium
laser incision of the prostate (1). Table 1 presents the age
and home uroflowmetry statistics for each patient. The med-
ian (25–75th percentile) age of men who completed the study
was 72 years (67–75 years). Although patients were
instructed to use the home flowmeter for 1 week, several
continued to do so for longer, for up to a maximum of
2 weeks as dictated by the device’s operational period. All
voids were included for analysis. Patients recorded a mean
(SD) of 54 (25) voids before surgery and 54 (21) voids after-
13 cm
Fig. 1 The device used for home uroflowmetry: the measurement base unit
(left) and the jug on top of the base unit ready for use (right).
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wards. The mean (minimum – maximum) number of voids
recorded per day was 8 (2–15) before surgery and 6 (2–9)
afterwards (P = 3 9 104, paired t-test). Automated and
manual calculations of Qmax were within 1 mL/s for 91% of
voids and within 2 mL/s for 95%. For Vvoid, 92% were
within 10 mL and 96% within 20 mL. Manual verification
and, if necessary, correction took between 2 and 15 min per
study, depending on the number of voids recorded and cor-
rections required.
Table 2 compares pre- and postsurgery values for mean
Qmax, mean Vvoid, total IPSS score, IPSS QOL score, IPSS
voiding subscore (sum of IPSS intermittency, weak stream
and straining scores) and IPSS storage subscore (sum of IPSS
frequency, urgency and nocturia). A total of 24 patients
(80%) experienced a significant increase in Qmax after sur-
gery, and 16 (53%) experienced a significant increase in Vvoid
(P < 0.05, multiple measurements in each man compared
before and after surgery using the independent t-test). The
median (25–75th percentile) length of time between surgery
and follow up was 170 days (156–213 days). There was no
correlation between length of time from surgery to follow up
and any of the following: increase in mean Qmax, increase in
mean Vvoid or decrease in total IPSS score (all P > 0.05,
Spearman’s rank).
For every patient, Qmax@Vol was calculated at 5-mL inter-
vals from 0 to 500 mL from presurgery home uroflowmetry
data. At all volumes, Qmax@Vol for the group showed the
expected negative correlation (q < 0) with both outcome
measures, showing that men with lower presurgery flow rates
tended to experience better outcomes. Qmax@Vol values for
volumes above 190 mL correlated significantly (P < 0.05)
with both objective and symptom outcome. Figure 4 shows
how rho and P-values changed depending on the volume at
which Qmax@Vol was corrected. For objective outcome,
correlation improved with increasing volume, plateauing at
300 mL, where rho was less than 0.46 (95% confidence
interval 0.12 to 0.70) and P < 0.01 (moderate correlation;
Fig. 4a). A similar, but less pronounced, pattern was
observed for the correlation between Qmax@Vol and symp-
tom outcome (Fig. 4b). Figure 5 shows volume-corrected
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Fig. 2 Examples of Qmax versus Vvoid for each void recorded using the home flowmeter for two patients. The lines show the equationsffiffiðp QmaxÞ ¼ ðb1Þ 
ffiffiðp VvoidÞ þ ðb2Þ calculated for each man from his data points. The plots are superimposed over the Liverpool nomogram for maximum flow rate
in men aged 50 years and older. The grey lines are the 5–95th centiles from this nomogram, as shown on the first plot.
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Fig. 3 An example of Qmax versus Vvoid data
points and their best fit square root relationship
for one patient, illustrating the calculation of
volume-corrected Qmax at 100, 300 and 500 mL.
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Qmax at 300 mL (Qmax@300) versus (i) increase in mean
Qmax from home uroflowmetry and (ii) percentage decrease
in total IPSS score after surgery, both with linear least
squares line of best fit.
Given that the flow rate is reported to the nearest 1 mL/s,
it would be sensible to record enough voids such that inclu-
sion of additional voids does not change Qmax@300 by more
than 0.5 mL/s.10 This was calculated for each individual,
and the highest void number at which this occurred was 21.
We defined a man’s Qmax  Vvoid relationship as one that
“fit” the Liverpool nomogram if it intersected fewer than two
of the Liverpool centile lines for Vvoid > 100 mL. Accord-
ingly, 14 (47%) did fit the Liverpool nomogram (e.g. Fig. 2a)
and 16 (53%) did not (e.g. Fig. 2b).
Discussion
Use of a single volume-corrected Qmax or nomogram catego-
rization of (Vvoid,Qmax) is used as a method to decide whether
an individual’s Qmax is abnormally low, in order to determine
the likelihood of BOO and guide clinical management. Meth-
ods reported previously have derived a relationship between
volume and Qmax using a single or small number of voids
from each individual in a large group of asymptomatic men.
Table 1 Age and, from pre-surgery home uroflowmetry, number of voids (Nvoids), mean (SD) Vvoid and mean (SD) Qmax for each man
No.
Age
(years) Nvoids
Mean (SD)
Vvoid (mL)
Mean (SD)
Qmax (mL/s) No. Age Nvoids
Mean (SD)
Vvoid (mL)
Mean (SD)
Qmax (mL/s)
1 79 86 104 (49) 6.3 (2) 16 68 34 225 (65) 13.7 (2.5)
2 71 66 142 (64) 9.4 (2.7) 17 70 79 176 (102) 9.5 (2.9)
3 62 46 240 (134) 13.4 (3.6) 18 73 46 184 (86) 10.9 (1.3)
4 86 63 92 (46) 4.1 (1.1) 19 67 34 310 (166) 16.3 (5.2)
5 76 55 130 (42) 9.8 (2.9) 20 75 81 188 (82) 10.3 (2.5)
6 70 64 114 (50) 6.8 (2.1) 21 65 25 102 (44) 3 (0.7)
7 55 38 225 (97) 6.6 (1.2) 22 75 66 106 (31) 6.2 (2.1)
8 83 60 110 (68) 8.7 (2.7) 23 68 14 252 (136) 7.4 (2.4)
9 67 29 337 (135) 12.1 (3.9) 24 63 48 213 (95) 13.8 (3.2)
10 74 42 141 (63) 11.6 (3.8) 25 81 76 159 (58) 10.3 (2.8)
11 73 33 249 (108) 12.3 (2.5) 26 73 60 104 (49) 7.8 (2.5)
12 68 54 214 (67) 5.8 (1.5) 27 68 44 203 (68) 6.9 (1.6)
13 84 59 114 (47) 6.9 (2.1) 28 72 24 119 (33) 5.4 (1.5)
14 64 62 229 (94) 11.2 (1.4) 29 72 64 200 (85) 9.7 (1.8)
15 89 146 102 (68) 3.9 (1.7) 30 62 31 152 (61) 6 (1.8)
Table 2 Comparison of outcomes before and subsequent to bladder
outlet surgery in the study population
Presurgery Postsurgery P-value
Mean Qmax (mL/s)† 8.9 (3.3) 17.8 (8.2) 2 9 10
6
Mean Vvoid (mL)† 175 (66) 220 (71) 1 9 10
4
IPSS total‡ 21 (16–24) 7.5 (3–10) 2 9 106
IPSS QOL‡ 5 (4–6) 2 (0–3) 3 9 106
IPSS voiding‡ 8 (6–10) 1 (0–3.5) 3 9 106
IPSS storage‡ 9.5 (8–11) 5 (3–7) 5 9 106
Total n = 30. †Mean (SD) values and P-value of the comparison accord-
ing to the paired t-test. ‡Median (25–75th percentile) values and P-value
of the comparison according to the Wilcoxon signed rank test.
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Either Vvoid, measured by the flowmeter, or Vblad, determined
by summing Vvoid and PVR, have been used. A single flow
measurement from a man with LUTS is then evaluated in this
context. This approach risks poor diagnostic and prognostic
accuracy if the patient under assessment does not show the
assumed relationship between Qmax and Vvoid. Sonke et al.
found this relationship to differ considerably between individ-
uals, with one-third having a negative relationship (decrease
in Qmax with increasing Vvoid).
7 Only a large number of mea-
surements obtained from an individual allow their true rela-
tionship to be determined with statistical confidence. This is
made possible by asking patients to carry out uroflowmetry
on multiple occasions at home, or elsewhere, during their
day-to-day life.
A group of men with LUTS will include men with BOO,
men with DO, men with both BOO and DO, and men with
neither. Bladder outlet surgery is thought to achieve better
outcomes in men with BOO than those without, and symp-
toms associated with DO in men with BOO have been
observed to improve after disobstructive surgery.13,14 Ideal
candidates for surgery are therefore men with BOO, with or
without coincident DO. A one-off measurement of flow with
low Vvoid and low Qmax cannot differentiate a man with BOO
from one with pure DO, in whom disobstructive surgery is
less likely to give benefit. The method presented in this study
allows estimation of Qmax at any volume by extrapolation of
serial voids, which might be low volume. This means that
there is in effect no lower volume limit for flow data
acquired in this way, which is a step forward for non-
invasive diagnostics.
The present study, using this approach, found that a vol-
ume-corrected Qmax calculated for each man from paired
measurements of Qmax and Vvoid correlates well with outcome
from disobstructive surgery, suggesting that it might be valu-
able in predicting who would benefit from surgical treatment.
For objective outcome, better and statistically significant cor-
relation was measured for volume-corrected Qmax at volumes
of 300 mL and above, which might reflect the average vol-
ume above which the detrusor must be stretched to generate
its greatest contractile force. Thus, the present results suggest
that the optimum volume is at least twice the 150 mL recom-
mended minimum Vvoid for a valid office-based flow test.
3,4
Fixing a point of origin at (Vvoid,Qmax) = (0,0) allows
mathematical calculation of a square root relationship from
just one void, but an estimate based on a few voids is inaccu-
rate. With each additional recorded void, Qmax@300 tends
towards its true value. In the present study, for no patient
was there any practical improvement in accuracy beyond 21
voids. For future larger scale independent validation studies,
we therefore recommend that at least 21 voids are recorded
per man for reliable calculation of Qmax@300. All but one of
our participants recorded at least this number (Table 1),
despite no minimum being requested.
The process of fitting an equation to predict Qmax from
Vvoid was carried out using MATLAB vR2012 software. In
future, these calculations could be built into the home
uroflowmetry analysis software for presentation alongside
other summary statistics from the study.
Previously, subjective outcome from surgery has been
defined by percentage improvement in IPSS, with <50%
classed as “poor” outcome and ≥50% classed as “good.”8,9
Thus, from Figure 5b, one may apply a threshold of 14 mL/s
to Qmax@300, because at this value the line of best fit
between Qmax@300 and percentage decrease in IPSS after
surgery equals 50%. A threshold approach like this is often
favored for research purposes, allowing cases to be grouped
and compared. However, it would be more valuable clinically
to use the relationship between Qmax@300 and outcome to
inform a man of the improvements in symptoms and flow
rate expected on average for a man with similar presurgery
flow volume characteristics. This could inform the decision
of whether or not to undergo surgery.
Few previous studies have correlated presurgery
uroflowmetry parameters with outcome. Oh et al. measured
in 134 men the correlations between pretransurethral resec-
tions of the prostate BOO index both pre-surgery Qmax from
single clinic uroflowmetry (q = 0.26, P = 0.002) and
improvement in IPSS storage subscore (q = 0.19,
P = 0.032).15 However, this was a different population of
patients, preselected according to BOO index, and using
Pearson’s analysis, which produces weaker correlation for
non-linear relationships.
As a feasibility study, this suffered from several limita-
tions. Different surgical procedures were carried out, although
all were carried out to relieve BOO. There was variation in
the diagnostic workup and treatment history of participants,
and subgroup analyses would have lacked statistical power.
All patients were deemed by their urologist to be suitable for
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disobstructive bladder outlet surgery, although pressure-flow
studies to confirm BOO were carried out only in men with
higher operative risk (fewer than half). There was variation in
time between surgery and follow up for logistical reasons,
but most men were reinvestigated at 4–6 months, and no dif-
ference in outcomes was observed according to time to fol-
low up. Despite these limitations, a significant relationship
between Qmax@Vol and surgical outcome was shown. For
reasons described earlier, a volume-corrected Qmax should
perform better than a single office-based measurement in
terms of predicting treatment outcome. However, the lack of
a direct comparison in the present study, because of the
unavailability of these results in a number of participants,
was another limitation.
We now plan to investigate the diagnostic and prognostic
value of Qmax@Vol in larger groups of men with LUTS.
The most appropriate function to predict Qmax from Vvoid
for a cohort (in this case a square root function) is not nec-
essarily the most appropriate for each man (this is a recog-
nized phenomenon: “Simpson’s paradox” describes the
general situation where a group relationship is non-existent
or reversed in the individual16). There is therefore scope for
further work to determine the most appropriate mathematical
function to predict Qmax from Vvoid in an individual. Indeed,
deviation from a normal pattern could indicate urological
abnormality, and classification of Qmax versus Vvoid patterns
related to different urological diseases would be of great
interest. A large normative dataset and method of quantify-
ing whether an individual fits a normal pattern are required.
It would be interesting to investigate the effect of the num-
ber of voids recorded and voided volumes on the clinical
value of Qmax@300.
In conclusion, we have devised a novel method for provid-
ing, for each individual, an estimate of Qmax at specific Vvoid,
using multiple home uroflowmetry. We found in a limited
patient sample that this volume-corrected Qmax at volumes
above 190 mL correlated well with treatment outcome, with
optimum volumes being 300 mL and above. Early data sug-
gest a threshold of 14 mL/s for Qmax@300. These results can
be used to power larger studies of the diagnostic and predic-
tive value of volume-corrected Qmax in men with LUTS.
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